Determination of Apoptotic Effect of Juglone on Human Bladder Cancer TCC-SUP and RT-4 Cells: An In Vitro Study
- J Environ Pathol Toxicol Oncol. 2018;37(2):173-181. doi: 10.1615/JEnvironPatholToxicolOncol.2018025226.
- 1. Department of Histology and Embryology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
- 2. Department of Nutrition and Dietetics, Faculty of Health Sciences, Süleyman Demirel University, Isparta, Turkey.
- 3. Department of Chemistry, Faculty of Arts and Sciences, Süleyman Demirel University, Isparta, Turkey.
This study aimed to investigate the effects of juglone on the human bladder carcinoma cell lines TCC-SUB and RT-4 in monolayer and spheroid cultures. Cells were treated with juglone at 24, 48, and 72 h of incubation. The activity of Caspase-3 was detected in vitro using a Caspase-3 colorimetric assay kit according to the manufacturer's instructions. The bromodeoxyuridine (BrdU) labeling index was used to determine the cells of the synthesis phase. The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay was used to determine the death of cells in both the monolayer and spheroid cultures. The control group had a large S-phase fraction and many of the TCC-SUB and RT-4 cells nuclei were observed to be positive for BrdU. The dead cell count was higher in the TCC-SUB and RT-4 cell lines with juglone applied than in the controls. We conclude that juglone significantly inhibits the proliferation and induces the Apoptosis of TCC-SUB and RT-4 cells in vitro.